Allium Labs, Inc. — Form D
Allium Labs, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-15. The offering totals $4.7M, of which $4.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-07-15
- Form: D
- Accession: 0001938040-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $4.2M
- Remaining: $500K
- Investors: 10
- Date of first sale: 2022-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-452560
Issuer
- Name: Allium Labs, Inc.
- CIK: 0001938040
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 169 Madison Ave. #2169, New York, NY, 10016
- Phone: (415) 763-0838
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Yi Sheng Chan | Director | New York, NY |
| Cheng Han Lee | Director | New York, NY |
| Yi Sheng Chan | Executive Officer | New York, NY |
| Cheng Han Lee | Executive Officer | New York, NY |
| David Beyer | Related Person | New York, NY |
| Tomasz Tunguz | Related Person | New York, NY |
| Cheng Han Lee | Related Person | New York, NY |
| Yi Sheng Chan | Related Person | New York, NY |
Other filings by this issuer (1)
More